Univec Financial Statements From 2010 to 2024

UNVC Stock  USD 0  0.0004  12.50%   
Univec financial statements provide useful quarterly and yearly information to potential Univec Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Univec financial statements helps investors assess Univec's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Univec's valuation are summarized below:
Univec Inc does not presently have any fundamental trend indicators for analysis.
Check Univec financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Univec's main balance sheet or income statement drivers, such as , as well as many indicators such as . Univec financial statements analysis is a perfect complement when working with Univec Valuation or Volatility modules.
  
This module can also supplement various Univec Technical models . Check out the analysis of Univec Correlation against competitors.

Univec Inc Company Return On Asset Analysis

Univec's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Univec Return On Asset

    
  -0.44  
Most of Univec's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Univec Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Univec Inc has a Return On Asset of -0.4376. This is 95.0% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.

Univec Inc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Univec's current stock value. Our valuation model uses many indicators to compare Univec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Univec competition to find correlations between indicators driving Univec's intrinsic value. More Info.
Univec Inc is rated first in return on asset category among its peers. It is rated second in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Univec by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Univec's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Univec Financial Statements

Univec stakeholders use historical fundamental indicators, such as Univec's revenue or net income, to determine how well the company is positioned to perform in the future. Although Univec investors may analyze each financial statement separately, they are all interrelated. For example, changes in Univec's assets and liabilities are reflected in the revenues and expenses on Univec's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Univec Inc. Please read more on our technical analysis and fundamental analysis pages.
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. The company was founded in 1992 and is based in Baltimore, Maryland. UNIVEC INC operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Univec Pink Sheet

Univec financial ratios help investors to determine whether Univec Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Univec with respect to the benefits of owning Univec security.